The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of MiR-1290 and its potential targets with characteristics of estrogen receptor α-positive breast cancer.
Yumi Endo
No relevant relationships to disclose
Tatsuya Toyama
No relevant relationships to disclose
Satoru Takahashi
No relevant relationships to disclose
Nobuyasu Yoshimoto
No relevant relationships to disclose
Mai Iwasa
No relevant relationships to disclose
Tomoko Asano
No relevant relationships to disclose
Yoshitaka Fujii
No relevant relationships to disclose
Hiroko Yamashita
No relevant relationships to disclose